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Summary The authors report the case of a 9-year-old Caucasian girl, born in northern Portugal, with
chronic nonspherocytic haemolytic anaemia and without family history of anaemia. The
aethiological study of this anaemia revealed pyruvate kinase deficiency (PKD), because of
two previously described mutations (426Arg ﬁ Trp and 510Arg ﬁ Gln). Since the blood
smear revealed features not fully compatible with PKD diagnosis, additional tests were
performed for the propositus and her parents, namely red blood cell membrane protein
analysis. A decrease in proteins band 3 (15%) and 4.2 (18%) was found in the propositus.
Her father presented only a decrease in band 3 (11%). Coexistence of PKD and erythrocyte
membrane proteins deficiency in the same patient is very uncommon. Our findings suggest
that a careful blood smear observation may lead to the identification of a combined defi-
ciency in erythrocyte membrane proteins and enzymopathies.
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Introduction
Pyruvate kinase (PK) deficiency is the most common
enzyme abnormality in the erythrocyte glycolytic pathway
causing hereditary chronic nonspherocytic haemolytic
anaemia. Usually, clinical manifestations are only present
in homozygous or compound heterozygous subjects for
different gene mutations (Baronciani & Beutler, 1993;
Kanno, Fujii & Miwa, 1993; Demina et al., 1998; Ferreira
et al., 2000). Considering the heterogeneity of the under-
lying molecular defects, it is not always possible to make a
precise genotype/phenotype correlation. Heterozygote car-
riers of the enzyme deficiency are usually devoid of clinical
manifestations (Demina et al., 1998; Ferreira et al., 2000).
Red cell morphology is commonly unremarkable, display-
ing some degree of anisocytosis and polychromatophilia
with a variable number of contracted echinocytes (small
densely staining spiculated cells), which usually become
more numerous after splenectomy (Zanella & Bianchi,
2000).
Band 3, the red cell anion exchanger, is a member of a
widely distributed family of proteins present in many
tissues, which play part in many cellular processes
involving the exchange transport of anions across
membranes (Kollert-Jons et al., 1993; Sahr et al., 1994;
Schofield et al., 1994). In red cells, band 3 enhances the
ability of blood to carry carbon dioxide from the tissues
to the lungs, and contributes to the stability and integrity
of the cell. Band 3 is the most representative protein in
RBC membrane and its deficiency is associated with
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20–40% (Hassoun & Palek, 1996) of all hereditary
spherocytosis cases, as well as with a few elliptocytosis
cases (namely southeast Asian ovalocytosis) (Jarolim
et al., 1991).
We describe a concomitant PK and band 3 deficiency in
a female child with chronic haemolytic anaemia.
Case report
The patient is a 9-year-old Caucasian girl born in northern
Portugal of nonconsanguineous parents with no known
family history of anaemia. She developed jaundice in the
first 24 h of life needing no specific treatment, and had a
history of chronic anaemia with sporadic iron supplemen-
tation.
We first saw the patient when she was 6 years old. She
presented normal physical and intellectual development.
Her skin was pale, the sclera slightly icteric and the spleen
was palpable 2.5 cm below the costal margin.
The basic haematological studies showed anaemia
(9.8 g/dl), reticulocytosis (398 · 109/l), high levels of total
and indirect bilirrubin (85 lmol/L and 80.5 lmol/L,
respectively), slightly high lactate dehydrogenase level
(463 IU/l) and undetectable haptoglobin levels. The blood
smear revealed red cell anisocytosis and anisochromia with
some elliptical and few tear drop-shaped erythrocytes
(Figure 1).
The aethiological study of this haemolytic anaemia
revealed a reduced PK activity of 2.2 IU/g Hb [normal
range (average ± 2 SD): 9.35 ± 2.3 IU/g Hb]. The
activity of the other erythrocyte glycolytic enzymes, as
well as the osmotic fragility test and the haemoglobin
electrophoresis pattern were normal, in the patient and
in her parents. Both parents presented PK activities in
the heterozygous range (father: 3.0 IU/g Hb; mother:
3.2 IU/g Hb). A direct sequencing of PKLR gene revealed
a compound heterozygosity in the patient for two
previously described mutations (Figure 2), 1276T
(426Arg ﬁ Trp) and 1529A (510Arg ﬁ Gln). Molecular
analysis of the TATA-box region of the UDP-glucuron-
osyltransferase-1 (UGT1A1) gene was made, reveal-
ing heterozygosity for a TA insertion [(TA)6/(TA)7]
(Figure 3).
Two years later, her haemoglobin levels dropped further
(first year average Hb: 9.15 g/dl; second year average Hb:
8.2 g/dl). At this time, splenectomy was performed.
Afterwards, haemoglobin levels showed a rise to stable
values above 10 g/dl; reticulocyte count increased to an
average of 688 · 109/l, and total bilirrubin levels fell to
around 29.2 lmol/L. Red blood cell morphology, as
expected after splenectomy, acquired slight different fea-
tures with the presence of some poikilocytes and echino-
cytes. Few elliptocytes were still seen (Figure 1), which led
us to search for membrane protein deficiencies. The
erythrocytes were isolated and their membranes obtained
and prepared according to Dodge, Mitchell and Hanahan
(1963). Protein concentration of the membrane suspen-
sions was determined (Bradford, 1976), and, after heat
denaturation, proteins were submitted to polyacrylamide
gel electrophoresis with sodium dodecyl sulphate (SDS-
PAGE), according to the methods of Laemmli (1970) and
Fairbanks, Steck and Wallach (1971). Proteins were
stained with Coomassie blue, and the gels were analysed
by a densitometer coupled to an image analysis software
(Bio-profil; Vilbert Lourmat, Torcy Marne-la-Valle´e,
France). We found a 15% decrease of band 3 and an
18% decrease of protein 4.2 in the patient, whereas the
father presented only a 11.3% decrease in band 3
(Figure 4), suggesting a primary band 3 deficiency in both.
Discussion
Unlike PK deficiency, which is a rare condition, band 3
deficiency is one of the most frequent causes of hereditary
Figure 1. Blood smear of the propositus, before (a) and after (b)
splenectomy.
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haemolytic anaemia. The combination of both is very
uncommon. To our knowledge, only one report by Zarza
et al. (2000) describes the combination of partial band 3
and protein 4.2 deficiency with heterozygosity for a
mutation in the PKLR gene. In the present case, the
patient presented a PK deficiency, with compound hetero-
zygosity for two PKLR mutations, combined with band 3
and protein 4.2 deficiency.
In the first approach to the patient, the clinical and, in
particular, the laboratorial features were not suggestive of
a membrane protein deficiency underlying the chronic
haemolytic anaemia presented by the patient. The only
feature present in this case, which made us suspect of
something more than just PK deficiency, was the obser-
vation of elliptocytic cells in the blood smear. Moreover,
Figure 2. Extract of direct sequencing of exon 10 and 11 of the PKLR gene. (a) Normal sequencing of exon 10. (b) Patient sequencing of
exon 10, with C and T peaks in nucleotide 1276 (426Arg ﬁ Trp). (c) Normal sequencing of exon 11. (d) Patient sequencing of exon 11,
with G and A peaks in nucleotide 1529 (510Arg ﬁ Gln).
Figure 3. Screening for UGT1A1 promoter variants, performed
by fluorescence-labelled polymerase chain reaction (PCR). The
amplified DNA fragment were separated by automated capillary
electrophoresis and analysed with ABI GeneScan program
(Applied Biosystems, Foster City, CA, USA). (a) Propositus sample
heterozygous for the mutant (TA)7 allele. (b) Control sample
homozygous for the (TA)7 allele.
Figure 4. Red cell membrane protein profiles in sodium dodecyl
sulphate polyacrylamide gel electrophoresis (SDS-PAGE) gels,
presented by a control (C), propositus (P) and father (F).
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the father, who was heterozygous for PK deficiency and
who also showed to present a band 3 deficiency, had no
remarkable morphological changes in the blood smear.
We did not find in the literature detailed descriptions of
other cases of compound heterozygosity for the two
described PK mutations, to which compare the clinical
and blood smear features presented by our patient.
After splenectomy of the propositous, her haemoglobin
levels stabilized at a higher level. This was accompanied by
an increase in the number of reticulocytes, which is a
common feature postsplenectomy in PK deficiency (Zanella
& Bianchi, 2000).
The most common genetic variant of UGT1A1 gene,
which is the main cause of Gilbert’s Syndrome in the
Portuguese population (Costa et al., 2002a), is a TA
insertion in the repetitive TATA-box of the gene promoter,
which normally consists of six repeats. In the present case,
heterozygosity for this TA insertion was also found. This
heterozygosity is thought to influence, albeit marginally,
the bilirrubin levels in patients with chronic haemolytic
anaemia (Costa et al., 2002b).
In PK deficiency, genotype/phenotype correlation is
difficult to establish. There is a great variability in the
possible combinations of the mutant alleles, and, even in
patients with the same known genotype (either in
homozygosity or compound heterozygosity), a significant
variability in phenotype is observed. Coinheritance of
erythrocyte membrane protein defects could influence this
observed variability. In our case, it is not possible to
demonstrate the interference of the present membrane
protein defect with the clinical picture shown by the
patient. Nevertheless, we believe that a careful blood
smear observation could lead to the identification of
combined enzyme and membrane protein deficiencies. By
doing so, it could be possible to better understand the
variability of the phenotypic manifestations and the
mutual interference of both deficiencies.
In conclusion, our report emphasizes the importance of
a careful blood smear observation in cases of chronic
haemolytic anaemia, and the need for additional studies,
whenever features do not entirely fit within the initially
proposed diagnosis.
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